NO20080553L - Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander - Google Patents
Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 liganderInfo
- Publication number
- NO20080553L NO20080553L NO20080553A NO20080553A NO20080553L NO 20080553 L NO20080553 L NO 20080553L NO 20080553 A NO20080553 A NO 20080553A NO 20080553 A NO20080553 A NO 20080553A NO 20080553 L NO20080553 L NO 20080553L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxytrypyamine
- azinyl
- ligands
- sulfonylindazole
- derivatives
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title 1
- 108091005435 5-HT6 receptors Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70831705P | 2005-08-15 | 2005-08-15 | |
| PCT/US2006/030837 WO2007032833A1 (en) | 2005-08-15 | 2006-08-08 | Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080553L true NO20080553L (no) | 2008-04-23 |
Family
ID=37315656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080553A NO20080553L (no) | 2005-08-15 | 2008-01-30 | Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7790751B2 (pt) |
| EP (1) | EP1915348A1 (pt) |
| JP (1) | JP2009504738A (pt) |
| KR (1) | KR20080034497A (pt) |
| CN (1) | CN101291913A (pt) |
| AR (1) | AR056459A1 (pt) |
| AU (1) | AU2006291414A1 (pt) |
| BR (1) | BRPI0614341A2 (pt) |
| CA (1) | CA2619309A1 (pt) |
| CR (1) | CR9733A (pt) |
| EC (1) | ECSP088176A (pt) |
| GT (1) | GT200600374A (pt) |
| IL (1) | IL189416A0 (pt) |
| MX (1) | MX2008002158A (pt) |
| NO (1) | NO20080553L (pt) |
| PE (1) | PE20070373A1 (pt) |
| RU (1) | RU2008103700A (pt) |
| SV (1) | SV2008002653A (pt) |
| TW (1) | TW200800913A (pt) |
| WO (1) | WO2007032833A1 (pt) |
| ZA (1) | ZA200801524B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2619010C (en) * | 2005-08-15 | 2013-10-01 | Wyeth | Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| AU2007274724B2 (en) * | 2006-07-14 | 2012-07-26 | Ranbaxy Laboratories Limited | Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof |
| MX2009004947A (es) * | 2006-11-09 | 2009-05-19 | Hoffmann La Roche | Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6). |
| US7939520B2 (en) | 2007-05-15 | 2011-05-10 | Wyeth Llc | Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| US20090012308A1 (en) * | 2007-06-13 | 2009-01-08 | Wyeth | Process for the manufacture of benzylsulfonylarenes |
| US8518933B2 (en) * | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
| EP2421870B1 (en) * | 2009-04-23 | 2016-03-09 | AbbVie Inc. | Modulators of 5-ht receptors and methods of use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200001234T2 (tr) | 1997-11-04 | 2000-08-21 | Pfizer Products Inc. | Terapötik aktif bileşiklerde katelkolün indazol biyoisoster değişimi. |
| WO2001005758A2 (en) | 1999-07-15 | 2001-01-25 | Nps Allelix Corp. | Indoles and indazoles for the treatment of migraine |
| EA200300717A1 (ru) * | 2000-12-22 | 2003-12-25 | Уайт | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов |
| PL366639A1 (en) * | 2001-04-20 | 2005-02-07 | Wyeth | Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| KR20030088508A (ko) | 2001-04-20 | 2003-11-19 | 와이어쓰 | 5-하이드록시트립타민-6 리간드로서의헤테로사이클릴옥시-, -티옥시- 및 -아미노벤즈아졸 유도체 |
| EP1403255A4 (en) | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | RHO KINASE INHIBITORS |
| US20050113283A1 (en) | 2002-01-18 | 2005-05-26 | David Solow-Cordero | Methods of treating conditions associated with an EDG-4 receptor |
| TW200400177A (en) | 2002-06-04 | 2004-01-01 | Wyeth Corp | 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| JP4754821B2 (ja) | 2002-06-20 | 2011-08-24 | プロキシマゲン・リミテッド | 肥満症、ｉｉ型糖尿病およびｃｎｓ障害の治療に有用な新規化合物 |
| TW200401641A (en) * | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| TW200412945A (en) * | 2002-10-25 | 2004-08-01 | Upjohn Co | Quaternary ammonium compounds |
| CN100422171C (zh) * | 2003-02-14 | 2008-10-01 | 惠氏公司 | 作为5-羟色胺-6配体的杂环-3-磺酰基吲唑 |
| KR20060114022A (ko) | 2004-02-27 | 2006-11-03 | 에프. 호프만-라 로슈 아게 | 인다졸 유도체 및 그들을 함유하는 약학 조성물 |
-
2006
- 2006-08-08 KR KR1020087005479A patent/KR20080034497A/ko not_active Withdrawn
- 2006-08-08 AU AU2006291414A patent/AU2006291414A1/en not_active Abandoned
- 2006-08-08 CN CNA2006800299549A patent/CN101291913A/zh active Pending
- 2006-08-08 EP EP06800937A patent/EP1915348A1/en not_active Withdrawn
- 2006-08-08 CA CA002619309A patent/CA2619309A1/en not_active Abandoned
- 2006-08-08 BR BRPI0614341-5A patent/BRPI0614341A2/pt not_active Application Discontinuation
- 2006-08-08 RU RU2008103700/04A patent/RU2008103700A/ru not_active Application Discontinuation
- 2006-08-08 WO PCT/US2006/030837 patent/WO2007032833A1/en not_active Ceased
- 2006-08-08 MX MX2008002158A patent/MX2008002158A/es unknown
- 2006-08-08 JP JP2008526990A patent/JP2009504738A/ja not_active Withdrawn
- 2006-08-14 AR ARP060103550A patent/AR056459A1/es unknown
- 2006-08-14 US US11/504,243 patent/US7790751B2/en not_active Expired - Fee Related
- 2006-08-14 SV SV2006002653A patent/SV2008002653A/es unknown
- 2006-08-14 TW TW095129788A patent/TW200800913A/zh unknown
- 2006-08-14 PE PE2006000985A patent/PE20070373A1/es not_active Application Discontinuation
- 2006-08-14 GT GT200600374A patent/GT200600374A/es unknown
-
2008
- 2008-01-30 NO NO20080553A patent/NO20080553L/no not_active Application Discontinuation
- 2008-02-10 IL IL189416A patent/IL189416A0/en unknown
- 2008-02-12 EC EC2008008176A patent/ECSP088176A/es unknown
- 2008-02-14 ZA ZA200801524A patent/ZA200801524B/xx unknown
- 2008-02-15 CR CR9733A patent/CR9733A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7790751B2 (en) | 2010-09-07 |
| ECSP088176A (es) | 2008-04-28 |
| JP2009504738A (ja) | 2009-02-05 |
| CN101291913A (zh) | 2008-10-22 |
| AR056459A1 (es) | 2007-10-10 |
| PE20070373A1 (es) | 2007-04-04 |
| CR9733A (es) | 2008-04-02 |
| RU2008103700A (ru) | 2009-09-27 |
| CA2619309A1 (en) | 2007-03-22 |
| MX2008002158A (es) | 2008-04-19 |
| WO2007032833A1 (en) | 2007-03-22 |
| KR20080034497A (ko) | 2008-04-21 |
| GT200600374A (es) | 2007-03-29 |
| IL189416A0 (en) | 2008-06-05 |
| SV2008002653A (es) | 2008-04-11 |
| BRPI0614341A2 (pt) | 2011-03-29 |
| TW200800913A (en) | 2008-01-01 |
| AU2006291414A1 (en) | 2007-03-22 |
| ZA200801524B (en) | 2010-04-28 |
| US20070054896A1 (en) | 2007-03-08 |
| EP1915348A1 (en) | 2008-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20050007L (no) | 1-Heterosyklylalkyl-3-sulfonylazaindol eller -azaindazolderivater som 5-hydroksytryptamin-6 ligander | |
| NO20050014L (no) | 1-Heterosyklylalkyl-3-sulfonylindol eller -indazolderivater som 5-hydroksytryptamin-6 ligander | |
| NO20090295L (no) | Substituerte heteroarylderivater | |
| NO20082136L (no) | 1,5-substituerte indol-2-yl-amidderivater | |
| NO20081454L (no) | Met-kinaseinhibitorer | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| WO2007142905A3 (en) | 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands | |
| NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
| EA200970402A1 (ru) | Триазолопиридазиновые модуляторы протеинкиназ | |
| NO20075082L (no) | Pyridin-3-karboksamidderivater som CB1-inversagonister | |
| MA32508B1 (fr) | Composes organiques | |
| NO20075624L (no) | Nye histamin H3-reseptorligander og deres terapeutiske anvendelser | |
| NO20080981L (no) | Nitrocatechol-derivater som COMT-inhibitorer | |
| NO20082285L (no) | 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer | |
| NO20093009L (no) | Kondensert ring heterocykel kinase modulatorer | |
| NO20082090L (no) | Pyridopyrimidinoninhibitorer av P13K alfa | |
| EA200901488A1 (ru) | Замещенные имидазолопиридазины, как ингибиторы липидкиназы | |
| MX2009011211A (es) | Indoles sustituidos en la posicion 7 inhibidores de mci-1. | |
| DK1888541T3 (da) | Benzo(d)isoxazol-3-yl-amin-forbindelser og anvendelse af disse som vanilloidreceptorligander | |
| NO20060202L (no) | Pyrrolodihydroisokinoliner som PDE-10-inhibitorer | |
| DK1771178T3 (da) | Anvendelse af K-252A og kinaseinhibitorer til forebyggelse eller behandling af HMGB1-assocuerede patologiske tilstande | |
| NO20082939L (no) | Sykloheksyl piperasinyl metanon derivater og anvendelse av disse som histamin H3 reseptor modulatorer | |
| NO20083058L (no) | Cykloheksylsulfonamidderivater med H3 reseptor aktivitet | |
| EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
| NO20080937L (no) | Substituerte-3-sulfonylindazolderivater som 5-hydroksytryptamin-6-ligander |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |